Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice

Autor: Hao, Zhenyue, Cairns, Rob A., Inoue, Satoshi, Li, Wanda Y., Sheng, Yi, Lemonnier, François, Wakeham, Andrew, Snow, Bryan E., Dominguez-Brauer, Carmen, Ye, Jing, Larsen, Dana M., Straley, Kimberly S., Tobin, Erica R., Narayanaswamy, Rohini, Gaulard, Philippe, Mak, Tak W.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 2016 Feb 01. 113(5), 1387-1392.

Externí odkaz: https://www.jstor.org/stable/26467611

Pan-cancer Analysis of Homologous Recombination Deficiency in Cell Lines.

Autor: Dodson AE; KSQ Therapeutics, Lexington, MA, United States., Shenker S; KSQ Therapeutics, Lexington, MA, United States., Sullivan P; KSQ Therapeutics, Lexington, MA, United States., Nayak SU; KSQ Therapeutics, Lexington, MA, United States., Middleton C; KSQ Therapeutics, Lexington, MA, United States., McGuire M; KSQ Therapeutics, Lexington, MA, United States., Chipumuro E; Dicerna Pharmaceuticals, Inc, Cambridge, MA, United States., Mishina Y; KSQ Therapeutics, Lexington, MA, United States., Tobin ER; KSQ Therapeutics, Lexington, MA, United States., Cadzow L; KSQ Therapeutics, Lexington, MA, United States., Wylie AA; KSQ Therapeutics, Lexington, MA, United States., Sangurdekar D; KSQ Therapeutics, Lexington, MA, United States.

Publikováno v: Cancer research communications [Cancer Res Commun] 2024 Nov 01. Date of Electronic Publication: 2024 Nov 01.